Ardelyx (ARDX) Profit After Tax (QoQ) (2013 - 2026)
Ardelyx (ARDX) Profit After Tax (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,218.67% |
| Dec 31, 2025 | 49.57% |
| Sep 30, 2025 | 95.78% |
| Jun 30, 2025 | 53.54% |
| Mar 31, 2025 | -979.23% |
| Dec 31, 2024 | 678.99% |
| Sep 30, 2024 | 95.08% |
| Jun 30, 2024 | 37.95% |
| Mar 31, 2024 | 7.46% |
| Dec 31, 2023 | -531.68% |
| Sep 30, 2023 | 138.77% |
| Jun 30, 2023 | 35.97% |
| Mar 31, 2023 | -347.51% |
| Dec 31, 2022 | 147.18% |
| Sep 30, 2022 | 15.00% |
| Jun 30, 2022 | 4.32% |
| Mar 31, 2022 | 22.30% |
| Dec 31, 2021 | 16.87% |
| Sep 30, 2021 | 3.54% |
| Jun 30, 2021 | -36.30% |